COVID-19 and immunosuppression: a review of current clinical experiences and implications for ophthalmology patients taking immunosuppressive drugs
Zheng Xian Thng(Tan Tock Seng Hospital), Rupesh Agrawal(Singapore National Eye Center), Marc D. de Smet(Université Libre de Bruxelles), Peter McCluskey(The George Institute for Global Health), Manfred Zierhut(Unknown), Justine R. Smith(Flinders University), Cecilia S. Lee(University of Washington), Vishali Gupta(Post Graduate Institute of Medical Education and Research), Quan Dong Nguyen(Smith-Kettlewell Eye Research Institute), John H. Kempen(Massachusetts Eye and Ear Infirmary), Jennifer E. Thorne(Johns Hopkins University), Carlos Pavésio(Moorfields Eye Hospital NHS Foundation Trust)
Cited by 106
Related Papers
Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension
|Nature Medicine|2020|1.2k
Choroidal vascularity index as a measure of vascular status of the choroid: Measurements in healthy eyes from a population-based study
|Scientific Reports|2016|721
Deep Learning Is Effective for Classifying Normal versus Age-Related Macular Degeneration OCT Images
|Ophthalmology Retina|2017|669
Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI extension
|Nature Medicine|2020|665
Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI extension
|The Lancet Digital Health|2020|453